| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.27 | 2e-07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.1 | 0.06 |